SPOTLIGHT -
New Products for April 7, 2003
FDA Approves Ruxolitinib Cream 1.5% to Treat Nonsegmental Vitiligo
Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
Merck, Ridgeback Announce EUA Submission for Investigational Oral Antiviral Molnupiravir for COVID-19
Merck and Ridgeback Biotherapeutics have announced their submission of an EUA application to the FDA for an oral antiviral medication for the treatment of COVID-19.
A Review of FDA-Approved Medications for Chronic Weight Management
Five medications are currently approved by the FDA for chronic weight management.
Fixed-Dose Combo Cream Treatment Approved for Acne Vulgaris
Sol-Gel Technologies has created a single-application acne treatment cream, combining 2 commonly used ingredients: tretinoin and benzoyl peroxide.
FDA OKs Treatment for Adolescents With Type 2 Diabetes
The FDA has approved the AstraZeneca once-weekly injectable therapy for use in children aged 10 to 17 years.
